Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

NCT00870519 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an imaging biomarker of brain amyloid.

Conditions

Interventions

Sponsor

Institute for Neurodegenerative Disorders